Compass Therapeutics Inc.

09/06/2024 | Press release | Archived content

Notice of Effectiveness - Form EFFECT

Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 6, 2024 4:01 P.M.
Form: S-3
CIK: 0001738021
Company Name: Compass Therapeutics, Inc.
File Number: 333-281891